Regulating biopharmaceuticals under CDER versus CBER: an insider's perspective
William D. SchwietermanVolume:
11
Year:
2006
Language:
english
Pages:
7
DOI:
10.1016/j.drudis.2006.08.011
File:
PDF, 216 KB
english, 2006